AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ICHR
ACCE-researched

Ichor Holdings Ordinary Shares (ICHR) fair value

Technology · Semiconductor Equipment & Materials · NASDAQ · United States
$37.94+0.21%
Market cap $1.4BNext earnings 2026-11-02Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 55% below our fair value
Price
$37.94
Model fair valueConfidence: low
about $84.62
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionIchor Holdings Ordinary Shares (ICHR)
Fair value (2 models)
Not available
ACCE price target
$41.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 17 Oct 2026, 00:00 CEST; previously $60.00 since 28 Sept 2026, 00:00 CEST.
Price used: $37.94 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
41
out of 100
Analysts
88% buy
8 covering
1-year return
+71.7%
Dividend yield
0.00%

Ichor Holdings Ordinary Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Ichor designs and makes fluid delivery subsystems that supply gases and chemicals to semiconductor fabrication tools. It is a key supplier to a few leading equipment makers, which gives it steady volume but weak pricing power. Wafer fab equipment spending is the main driver. Revenue grew 22.7%, but the gross margin is 12.7% and the operating margin 2.8%, at 17.2x forward earnings.

AI-assisted·How I use AIWritten Oct 14, 2026
⚠ Investor warnings · 5 flagsAI-assisted·How I use AI
  • high
    Earnings collapse despite revenue growth
    Revenue up 22.7% YoY but earnings down 6.1%; net margin negative at -4.0%. Profitability deteriorating while top line expands signals margin pressure or cost control issues.
  • high
    Negative ROE and cash generation weak
    ROE -5.2% indicates shareholder value destruction. FCF of $10M on $2.2B market cap (0.45% yield) insufficient to support valuation or debt service.
  • moderate
    Valuation stretched on forward metrics
    Forward P/E 18.2 and EV/EBITDA 57.1 are elevated for a company with negative current profitability and decelerating earnings. Fair value range $42-$78 wide, suggesting model uncertainty.
  • moderate
    Long-term revenue decline masked by recent bounce
    5-year revenue CAGR -9.5% despite recent QoQ +15.1% and YoY +22.7%. Suggests cyclical recovery rather than structural growth; sustainability unclear.
  • moderate
    Insider selling without offsetting buying
    Last 10 disclosures show $4.02M in insider sales and $0 in buys. No insider conviction signal at current price levels.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue jumped 22.7% year over year, suggesting strong demand recovery in semiconductor equipment after a prolonged downturn.
  • Analyst consensus is overwhelmingly bullish, with 86% rating the stock Buy or Strong Buy and a mean target 57.1% above current price.
  • The company beat earnings expectations by 4.8% and maintains a conservative debt to equity ratio of 0.18, leaving room to invest or return capital.
Why it could disappoint
  • Earnings per share fell despite 22.7% revenue growth, with the company posting negative 4.0% net margin and negative 5.5% return on invested capital.
  • Forward P/E of 18.2x and free cash flow yield of only 0.5% leave little margin for error if the semiconductor cycle turns.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 2, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ICHR's valuation models land
Price
$37.94
Model fair valueConfidence: low
about $84.62
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish88% buy · 8 covering analysts
● Strong buy 6● Buy 1● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
0 buys · 1 sell
Since Jun 17, 2026, 1 member
Average delay
27 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-9.9%
1 month
-35.0%
3 months
-56.2%
6 months
-46.5%
YTD
+105.9%
1 year
+71.7%

SEC filings

Recent ACCE blog coverage

  • $ICHR Score Drops 18 Points to 26 as Valuation Gap Widens
    Ichor Holdings' ACCE composite score fell from 44 to 26. Here's what the data shows across growth, value, quality, and momentum dimensions.
    2026-06-23

Recommendation history, last 12 months

DateTypeNewPreviousPrice
17 Oct 2026, 00:00 CESTACCE price target$41.00$60.00$42.11
4 Oct 2026, 00:00 CESTFair value$2.73$2.77$62.92
30 Sept 2026, 00:00 CESTFair value$2.77$2.67$59.42
28 Sept 2026, 00:00 CESTACCE price target$60.00first publication$57.94
26 Sept 2026, 00:00 CESTFair value$2.67$2.82$56.47
23 Sept 2026, 00:00 CESTFair value$2.82$2.76$56.14
21 Sept 2026, 00:00 CESTFair value$2.76$2.59$54.80
19 Sept 2026, 00:00 CESTFair value$2.59$2.48$52.96
16 Sept 2026, 00:00 CESTFair value$2.48$2.76$51.38
14 Sept 2026, 00:00 CESTFair value$2.76$2.71$57.35

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ICHR page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth52Value33Quality31Momentum46Total41
Valuation
Trailing P/E
no data
Forward P/E
11.5x
PEG
no data
P/B
2.53x
EV / Revenue
2.1x
Book value/sh
$23.15
Enterprise value
$2.1B
Profitability
ROE
-5.2%
FCF yield
-0.44%
ROIC
-5.3%
Health and risk
Debt / equity
0.24
Dividend yield
0.00%
Beta
1.79

Price

+68.8% · 1Y

Ask anything about ICHR

Answered from Ichor Holdings Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 17% of peers
low -9%-5%high 3%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ICHR Ichor Holdings Ordinary Shares$37.94----5.2%3141
SILEX.ST Silex Microsystems AB (publ)kr 136.75kr 8267% above40.8x0.0%8061
AEHR Aehr Test Systems Common Stock$55.31----4.2%3940
UCTT Ultra Clean Holdings Inc. Common Stock$45.32----1.6%3142
COHU Cohu Inc. Common Stock$47.96----4.8%3949
VECO Veeco Instruments Inc. Common Stock$42.06$2661% above113.7x2.6%5147
AMBA Ambarella Inc. Ordinary Shares$66.50----9.4%4335

Sector report card

Where ICHR ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 7, 2026
    Ichor to Announce Third Quarter 2026 Financial Results on November 2nd
  • Business Wire•Sep 28, 2026
    Ichor Announces Participation in 18th Annual CEO Investor Summit
  • Business Wire•Aug 3, 2026
    Ichor Holdings, Ltd. Announces Second Quarter 2026 Financial Results
2 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 5
Form 4Insider transactionPeriod 2026-10-02
View on SEC →
Oct 5
Form 4Insider transactionPeriod 2026-10-01
View on SEC →
September 2026
Sep 16
Form 4Insider transactionPeriod 2026-09-15
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR